These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 850907)

  • 21. Localization of the binding site of tissue-type plasminogen activator to fibrin.
    Ichinose A; Takio K; Fujikawa K
    J Clin Invest; 1986 Jul; 78(1):163-9. PubMed ID: 3088041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen.
    McClintock DK; Englert ME; Dziobkowski C; Snedeker EH; Bell PH
    Biochemistry; 1974 Dec; 13(26):5334-44. PubMed ID: 4279693
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
    Husain SS; Lipinski B; Greuwich V
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
    Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
    Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B
    Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
    Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function.
    Christensen U
    Biochem J; 1984 Oct; 223(2):413-21. PubMed ID: 6437391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of a low molecular weight form of plasminogen.
    Paoni NF; Castellino FJ
    Biochem Biophys Res Commun; 1975 Jul; 65(2):757-64. PubMed ID: 125089
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasminogen-binding site of the thermostable region of fibrinogen fragment D.
    Lezhen TI; Kudinov SA; Medved' LV
    FEBS Lett; 1986 Mar; 197(1-2):59-62. PubMed ID: 3081373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.
    Fleury V; Loyau S; Lijnen HR; Nieuwenhuizen W; Anglés-Cano E
    Eur J Biochem; 1993 Sep; 216(2):549-56. PubMed ID: 8375393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
    Mulichak AM; Tulinsky A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe.
    Miles LA; Plow EF
    Biochemistry; 1986 Nov; 25(22):6926-33. PubMed ID: 3099830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen fragments K 1-3 and K 5 bind to different sites in fibrin fragment DD.
    Grinenko TV; Kapustianenko LG; Yatsenko TA; Yusova OI; Rybachuk VN
    Ukr Biochem J; 2016; 88(3):36-45. PubMed ID: 29235323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Binding of lys-plasminogen to E-fragment of fibrinogen].
    Kudinov SA; Andrianov SI; Lezhen TI
    Biokhimiia; 1988 Oct; 53(10):1684-90. PubMed ID: 3233226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifications to the lysine Sepharose method of plasminogen purification which ensure plasmin-free Glu-plasminogen.
    Grant AJ
    Biochem Int; 1990; 20(3):519-27. PubMed ID: 2140680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.
    Dunn FW; Deguchi K; Soria J; Soria C; Lijnen HR; Tobelem G; Caen J
    Thromb Res; 1984 Nov; 36(4):345-51. PubMed ID: 6543039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.